Xiaofei Sun

455 total citations
68 papers, 262 citations indexed

About

Xiaofei Sun is a scholar working on Neurology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Xiaofei Sun has authored 68 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 17 papers in Pathology and Forensic Medicine and 16 papers in Oncology. Recurrent topics in Xiaofei Sun's work include Neuroblastoma Research and Treatments (19 papers), Lymphoma Diagnosis and Treatment (16 papers) and Acute Lymphoblastic Leukemia research (9 papers). Xiaofei Sun is often cited by papers focused on Neuroblastoma Research and Treatments (19 papers), Lymphoma Diagnosis and Treatment (16 papers) and Acute Lymphoblastic Leukemia research (9 papers). Xiaofei Sun collaborates with scholars based in China, Canada and Hong Kong. Xiaofei Sun's co-authors include Zijun Zhen, Jia Zhu, Junting Huang, Guolong Zhang, Xiuli Wang, Feifei Sun, Suying Lü, Yizhuo Zhang, Xiaofang Guo and Peiru Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Xiaofei Sun

61 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofei Sun China 10 81 79 52 48 43 68 262
Dubravka Sertić Croatia 9 74 0.9× 110 1.4× 28 0.5× 34 0.7× 29 0.7× 24 287
Jelena Roganović Croatia 11 52 0.6× 67 0.8× 34 0.7× 106 2.2× 39 0.9× 68 300
Bungo Saito Japan 14 59 0.7× 164 2.1× 29 0.6× 21 0.4× 17 0.4× 47 485
Jairam Krishnamurthy United States 12 119 1.5× 236 3.0× 32 0.6× 66 1.4× 9 0.2× 37 423
You Sun Lee South Korea 9 110 1.4× 30 0.4× 67 1.3× 57 1.2× 25 0.6× 15 423
F Cameron Australia 9 194 2.4× 110 1.4× 68 1.3× 82 1.7× 10 0.2× 17 413
G.K. Rath India 9 110 1.4× 86 1.1× 64 1.2× 147 3.1× 26 0.6× 34 339
Swaroop Revannasiddaiah India 10 115 1.4× 104 1.3× 24 0.5× 30 0.6× 24 0.6× 55 314
N Tallada Spain 13 138 1.7× 129 1.6× 80 1.5× 139 2.9× 22 0.5× 30 406
Kerry Thomas United States 12 73 0.9× 87 1.1× 54 1.0× 76 1.6× 26 0.6× 29 308

Countries citing papers authored by Xiaofei Sun

Since Specialization
Citations

This map shows the geographic impact of Xiaofei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Sun more than expected).

Fields of papers citing papers by Xiaofei Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Sun. The network helps show where Xiaofei Sun may publish in the future.

Co-authorship network of co-authors of Xiaofei Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Sun. A scholar is included among the top collaborators of Xiaofei Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Sun. Xiaofei Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lü, Suying, Changhong Wang, Junting Huang, et al.. (2024). Pegylated liposomal doxorubicin combined with cyclophosphamide and vincristine in pediatric patients with relapsed/refractory solid tumor: a single-arm, open-label, phase I study. EClinicalMedicine. 73. 102701–102701. 1 indexed citations
4.
Que, Yi, Juan Wang, Feifei Sun, et al.. (2023). Safety and clinical efficacy of sintilimab (anti-PD-1) in pediatric patients with advanced or recurrent malignancies in a phase I study. Signal Transduction and Targeted Therapy. 8(1). 392–392. 5 indexed citations
5.
Chen, Tingting, Juan Wang, Feifei Sun, et al.. (2023). Long‐term follow‐up results of pediatric and adolescent patients with localized Ewing sarcoma treated based on stratified modalities. Cancer Medicine. 12(8). 9409–9419. 1 indexed citations
6.
Yang, Qunying, Zhiqing Wei, Tingting Chen, et al.. (2023). Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study. Journal of Neuro-Oncology. 164(3). 643–653.
7.
Lü, Suying, Huimou Chen, Liu-Hong Wu, et al.. (2022). The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors. Frontiers in Pharmacology. 13. 711704–711704. 4 indexed citations
8.
Li, Zhuoran, Juan Wang, Feifei Sun, et al.. (2022). Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma. Frontiers in Oncology. 12. 1019106–1019106. 6 indexed citations
9.
Zhou, Zhongxia, Linglin Zhang, Haiyan Zhang, et al.. (2022). Topical 5-aminolevulinic acid photodynamic therapy with novel approach successfully treated refractory deep male urethral condyloma acuminata: A retrospective case series. Journal of the American Academy of Dermatology. 88(5). 1166–1169. 3 indexed citations
10.
Zhang, Guolong, et al.. (2021). Combination curettage and modified ALA-PDT for multiple basal cell carcinomas of the face and head. Photodiagnosis and Photodynamic Therapy. 35. 102393–102393. 11 indexed citations
11.
Lü, Suying, Xiaoqin Zhu, Wei Li, et al.. (2021). Influence of Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphism on High-Dose Methotrexate-Related Toxicities in Pediatric Non-Hodgkin Lymphoma Patients. Frontiers in Oncology. 11. 598226–598226. 10 indexed citations
12.
Sun, Xiaofei, et al.. (2021). Clinicopathological characteristics of placental chorioangioma: A clinicopathological study of 77 cases. Annals of Diagnostic Pathology. 57. 151873–151873. 4 indexed citations
13.
Zhao, Zijun, Zhongxia Zhou, Yan Zhao, et al.. (2021). ALA-PDT successfully treated multiple cSCC in situ and AK in a patient with Epidermodysplasia verruciformis. Photodiagnosis and Photodynamic Therapy. 35. 102395–102395. 6 indexed citations
14.
Shan, Fang, Zhongxia Zhou, Zhe Zheng, et al.. (2021). Photodynamic therapy combined with carbon dioxide laser for successful treatment of cutaneous squamous cell carcinoma within a long-standing and huge seborrheic keratosis. Photodiagnosis and Photodynamic Therapy. 36. 102536–102536. 3 indexed citations
15.
Chen, Chao, Yaohui Wang, Xiaofei Sun, et al.. (2020). Cardiac motion non-influential in percutaneous computed tomography-guided biopsies of small (≤ 20 mm) lung nodules near pericardium. Japanese Journal of Radiology. 38(9). 890–898. 1 indexed citations
16.
Chang, Hui, Xiaofei Sun, Zijun Zhen, et al.. (2016). Long-Term Outcomes of Nasopharyngeal Carcinoma in 148 Children and Adolescents. Medicine. 95(17). e3445–e3445. 19 indexed citations
17.
Li, Pengfei, Zijun Zhen, Zhuowei Liu, et al.. (2014). Effect of excision extension of primary tumors on local control and survival of stage IV neuroblastoma. Clinical Oncology and Cancer Research. 41(24). 1568–1572. 1 indexed citations
18.
Zhen, Zijun, et al.. (2012). The value of primary site radiotherapy in stage IV high-risk neuroblastoma. Zhonghua fangshe zhongliuxue zazhi. 21(1). 13–15. 1 indexed citations
19.
Zhen, Zijun, Xiaofei Sun, You‐Jian He, et al.. (2010). The sequence of drug administration influences the antitumor effects of bevacizumab and cyclophosphamide in a neuroblastoma model. Medical Oncology. 28(S1). 619–625. 6 indexed citations
20.
Sun, Xiaofei, et al.. (2007). [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].. PubMed. 26(8). 866–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dubravka Sertić Breakdown of academic impact, for papers by Jelena Roganović Breakdown of academic impact, for papers by Bungo Saito Breakdown of academic impact, for papers by Jairam Krishnamurthy Breakdown of academic impact, for papers by You Sun Lee Breakdown of academic impact, for papers by F Cameron Breakdown of academic impact, for papers by G.K. Rath Breakdown of academic impact, for papers by Swaroop Revannasiddaiah Breakdown of academic impact, for papers by N Tallada Breakdown of academic impact, for papers by Kerry Thomas
Rankless by CCL
2026